Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-30

FDA Approved: ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE — Supplemental Application (A2A Integrated Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for Isosorbide Dinitrate and Hydralazine Hydrochloride from A2A Integrated Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isosorbide Dinitrate and Hydralazine Hydrochloride (Isosorbide Dinitrate and Hydralazine Hydrochloride)

Snippet

SUPPL AP for ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE (ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE)